An epidemiological study of the use of ECT in adolescents

Journal of the American Academy of Child and Adolescent Psychiatry
G Walter, J M Rey

Abstract

There is little knowledge about the use of electroconvulsive therapy (ECT) in adolescents. Given the prevalence and severity of psychiatric disorders in this age group, it is important to determine the frequency, indications, effectiveness, and side effects of ECT. Persons younger than 19 years who received ECT between 1990 and 1996 in the Australian state of New South Wales were identified. Detailed information about diagnosis, treatment, and outcome was then obtained. Forty-two patients aged 14 to 18 years underwent a total of 49 courses comprising 450 ECTs (0.93% of all treatments given to all persons). Marked improvement or resolution of symptoms occurred in half of the completed courses. Mood disorders derived most benefit from ECT. Side effects were transient and minor. Prolonged seizures were observed in 0.4% of treatments. Comorbid personality disorder predicted poorer response, and the anesthetic propofol was associated with shorter seizures. Although ECT is an effective treatment for some mental disorders in adolescents and has few side effects, it is seldom used. Indications, response, and unwanted effects were similar to those observed in adults. The use of propofol may reduce the risk of prolonged seizures.

References

Jan 1, 1992·Journal of Affective Disorders·G ParkerF Pedic
Jun 1, 1991·The Australian and New Zealand Journal of Psychiatry·P MitchellC Burke
Apr 8, 1995·BMJ : British Medical Journal·P HazellD Henry
Jan 7, 1995·Lancet·T Baker
Nov 1, 1994·The American Journal of Psychiatry·J W ThompsonC P Myers
Feb 1, 1994·The American Journal of Psychiatry·S MukherjeeD B Schnur
Jan 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·L M Koran
May 1, 1997·The American Journal of Psychiatry·J M Rey, G Walter

❮ Previous
Next ❯

Citations

Jun 23, 2006·European Child & Adolescent Psychiatry·Taghi Esmaili, Ayyoub Malek
Dec 1, 2006·European Child & Adolescent Psychiatry·Angèle ConsoliDavid Cohen
Jan 22, 2009·European Child & Adolescent Psychiatry·Angèle ConsoliDavid Cohen
Feb 10, 2009·European Child & Adolescent Psychiatry·Lee E WachtelIrving M Reti
Mar 27, 2013·Paediatric Drugs·Victoria E CosgroveKiki D Chang
Nov 24, 2004·Journal of Affective Disorders·Daniel SteinAbraham Weizman
Sep 17, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·O TaiebD Cohen
Mar 27, 2003·The Australian and New Zealand Journal of Psychiatry·Anupam ThakurVinod Kumar Sinha
Jun 29, 2010·Journal of Child and Adolescent Psychopharmacology·Inmaculada BaezaJosefina Castro-Fornieles
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·G WalterJ M Rey
Aug 6, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·D CohenM Basquin
Nov 9, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·Y BlochG Ratzoni
Jul 11, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Wade Myers, Mathew Nguyen
Jun 7, 2003·The Journal of ECT·Garry Walter, Joseph M Rey
Aug 30, 2005·The Journal of ECT·Serene P C TehDeirdre G Drake
Apr 23, 2009·The Journal of ECT·Immaculada BaezaJosefina Castro-Fornieles
Nov 26, 2010·The Journal of ECT·Angèle ConsoliOlivier Bonnot
Dec 24, 1997·The Australian and New Zealand Journal of Psychiatry·G WalterJ Starling
Jan 20, 2016·Journal of Child and Adolescent Psychopharmacology·Chad C PufferMark A Frye
May 6, 2009·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Barbara SixtEberhard Schulz
Sep 6, 2006·Child and Adolescent Psychiatric Clinics of North America·David A Brent, Boris Birmaher
Mar 17, 2016·Journal of Child and Adolescent Psychopharmacology·Itziar FlamariqueJosefina Castro-Fornieles
Nov 27, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Neera GhaziuddinUNKNOWN AACAP
Oct 9, 2015·Journal of Child and Adolescent Psychopharmacology·Itziar FlamariqueInmaculada Baeza
Dec 3, 2014·Asian Journal of Psychiatry·Preeti JacobJohn Vijay Sagar
Jun 24, 2008·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Yuval BlochGideon Ratzoni
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Nov 23, 2007·Journal of Nutrition for the Elderly·Segametsi D Maruapula, Karen M Chapman-Novakofski
Jan 5, 2000·The British Journal of Psychiatry : the Journal of Mental Science·P YatesI Higginson
Jan 25, 2000·The British Journal of Psychiatry : the Journal of Mental Science·R DuffettP Lelliott
Mar 30, 1999·The Proceedings of the Nutrition Society·W C ChumleaS S Guo
Feb 3, 2005·Obesity Research·Richard N BaumgartnerJohn E Morley
Nov 13, 2019·Harvard Review of Psychiatry·Nicole M Benson, Stephen J Seiner
Nov 6, 2001·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·K Rabheru
Jan 31, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·B EtainM C Mouren-Simeoni
Nov 16, 2004·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Jose SegalJaco du Toit
Dec 17, 2010·Expert Review of Neurotherapeutics·Hazem Shoirah, Hesham M Hamoda
Jun 24, 2017·Frontiers in Psychiatry·Jonathan C LeePaul E Croarkin
Mar 4, 2020·Journal of Child and Adolescent Psychopharmacology·Neera GhaziuddinMohammad Ghaziuddin
Feb 3, 2021·The Psychiatric Clinics of North America·Sa Eun ParkSanjay Kaji
Sep 25, 1999·The Medical Journal of Australia·C WijeratneR W Lyndon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
L M Koran
Journal of Child and Adolescent Psychopharmacology
N GhaziuddinJ Greden
Journal of the American Academy of Child and Adolescent Psychiatry
F N Moise, G Petrides
The British Journal of Psychiatry : the Journal of Mental Science
R DuffettP Lelliott
© 2021 Meta ULC. All rights reserved